Article Text
Abstract
INTRODUCTION
The term paraneoplastic syndrome is now mainly reserved for non-metastatic manifestations of cancer that are considered to have some immunological explanation, i.e. they are not due to vascular disease, coagulopathy, infection, metabolic disorder, nutritional deficeincy or the complications of treatment. The frequency of neurological paraneoplastic syndromes is something less than 0.5 per 100 000 population per year. Over the last 10 years, there has been increasing understanding of their immunological mechanisms and many new antigens/antibodies have been described. It is likely that the next few years will see the description of even more and so the number of ‘antibody negative’ cases will continue to shrink.
PATHOGENESIS
The central theory of pathogenesis is that the syndromes are autoimmune in origin. The individual patient mounts an antibody response to one or more of their tumour antigens, and the antibodies produced cross react with molecular domains normally expressed on neurones. (Fig. 1).
Statistics from Altmetric.com
Other content recommended for you
- A rare case of long-term paraesthesia diagnosed as a paraneoplastic syndrome by anti-SOX1 antibody determination
- Which antibody and which cancer in which paraneoplastic syndromes?
- Republished: Which antibody and which cancer in which paraneoplastic syndromes?
- Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
- Paraneoplastic neurological syndrome as an initial indicator of small cell carcinoma of the lung
- Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma
- Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features
- Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary
- Successful treatment of peripheral paraneoplastic neurological syndromes in small cell cancer
- Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management